sglt2 inhibitors vs glp 1 agonists Diabetic Agents, From Metformin to and GLP1 Receptor Agonists: JACC Focus Seminar Use of SGLT2 inhibitors or

Portal hypertension and liver lesions in chronically alcohol drinking rats prevented and reversed by Stable Gastric pentadecapeptide BPC 157 (PL-10, PLD-116), and propranolol, but not ranitidine

These findings align with previous reports that melatonin reduces ILC2-derived IL-5 and IL-13 in oxazolone-induced colitis models (65), suggesting a conserved anti-inflammatory effect of melatonin across tissues

doi: 10.1038/s41589-020-0613-y 86 FreitasFPAlborziniaHDos SantosAFNepachalovichPPedreraLZilkaOet al

The risk varies by individual based on baseline B12 status, diet composition, and whether you have underlying conditions like pernicious anemia or metformin use (which also lowers B12)